Monday, August 18, 2025 9:03:34 AM
That tired “if Big Pharma wanted it, they’d already own it” line is weak. Pharma doesn’t gamble early — they let the smaller players do the heavy lifting, then swoop in once risk is de-risked. Silence doesn’t equal failure, it usually means they’re waiting for IDE clearance and first-in-human data before writing a big check.
Nanogels?
Nanogels sitting in labs ? RadioGel. Nanogels are just a delivery concept. RadioGel is a precision injectable hydrogel that traps Y-90 inside the tumor and keeps it there. That’s the leap nobody else has made.
If “nanogels have been around forever,” then where are the FDA-approved cancer treatments using them? Exactly. They don’t exist, because no one solved stability, containment, and precision dosing the way Vivos has. That’s why Mayo is backing it.
And the “worthless OTC” jab? Reality check: most pennies never move past fluffy PR. Vivos already has:
✔️ Peer-reviewed animal data
✔️ FDA-approved genotoxicity results
✔️ Mayo Clinic doctors trained on the system
✔️ Cash on hand with no toxic debt
Absurd? What’s absurd is pretending RadioGel is just another “me-too” science project. It’s first-of-its-kind, and the only thing left to prove it in humans is FDA’s green light — not the science itself.
$RDGL
Nanogels?
Nanogels sitting in labs ? RadioGel. Nanogels are just a delivery concept. RadioGel is a precision injectable hydrogel that traps Y-90 inside the tumor and keeps it there. That’s the leap nobody else has made.
If “nanogels have been around forever,” then where are the FDA-approved cancer treatments using them? Exactly. They don’t exist, because no one solved stability, containment, and precision dosing the way Vivos has. That’s why Mayo is backing it.
And the “worthless OTC” jab? Reality check: most pennies never move past fluffy PR. Vivos already has:
✔️ Peer-reviewed animal data
✔️ FDA-approved genotoxicity results
✔️ Mayo Clinic doctors trained on the system
✔️ Cash on hand with no toxic debt
Absurd? What’s absurd is pretending RadioGel is just another “me-too” science project. It’s first-of-its-kind, and the only thing left to prove it in humans is FDA’s green light — not the science itself.
$RDGL
Know what you own, and know why you own it.
Recent RDGL News
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
